Table 2. Detailed clinical information and follow-up data of 359 patients with ccRCC.
| Characteristics | Categories | Number |
|---|---|---|
| Overal survival median (range, months) | 63.01(1–144) | |
| Age median (range, years) | 55.78(15–85) | |
| Tumor size median (range, cm) | 1.25(1–14) | |
| Gender | ||
| Male | 254 | |
| Female | 103 | |
| TNM stage | ||
| T1 | 287 | |
| T2 | 55 | |
| T3 | 10 | |
| T4 | 7 | |
| pT stage | ||
| T1 | 289 | |
| T2 | 56 | |
| T3 | 10 | |
| T4 | 4 | |
| pN stage | ||
| N0(negative) | 350 | |
| N1(positive) | 9 | |
| pM stage | ||
| M0(Absent) | 353 | |
| M1(Present) | 6 | |
| Fuhrman grade | ||
| I | 117 | |
| II | 180 | |
| III | 56 | |
| IV | 6 | |
| Survival outcome | ||
| Dead | 56 | |
| Survival or lost | 303 | |
| 3-year survival rate(number) | 94.99%(341/359) |